[Evaluation of 12 months treatment with L-DOPA of patients with Parkinson's disease].
D000328:Adult; D000368:Aged; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004358:Drug Therapy / Q000592:standards; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*
D010276:Parasympatholytics; D004295:Dihydroxyphenylalanine
Evaluatie van 12 maanden L-DOPA-behandeling bij patiënten met de ziekte van Parkinson.